NuVasive, Inc.

NasdaqGS:NUVA 株式レポート

時価総額:US$2.1b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

NuVasive バランスシートの健全性

財務の健全性 基準チェック /36

NuVasiveの総株主資本は$892.5M 、総負債は$795.5Mで、負債比率は89.1%となります。総資産と総負債はそれぞれ$2.1Bと$1.2Bです。 NuVasiveの EBIT は$82.6Mで、利息カバレッジ比率6.1です。現金および短期投資は$80.7Mです。

主要情報

89.1%

負債資本比率

US$795.54m

負債

インタレスト・カバレッジ・レシオ6.1x
現金US$80.72m
エクイティUS$892.54m
負債合計US$1.20b
総資産US$2.09b

財務の健全性に関する最新情報

Recent updates

Is NuVasive (NASDAQ:NUVA) Using Too Much Debt?

Apr 18
Is NuVasive (NASDAQ:NUVA) Using Too Much Debt?

What Does NuVasive, Inc.'s (NASDAQ:NUVA) Share Price Indicate?

Jan 24
What Does NuVasive, Inc.'s (NASDAQ:NUVA) Share Price Indicate?

NuVasive, Inc.'s (NASDAQ:NUVA) Intrinsic Value Is Potentially 48% Above Its Share Price

Dec 31
NuVasive, Inc.'s (NASDAQ:NUVA) Intrinsic Value Is Potentially 48% Above Its Share Price

Capital Allocation Trends At NuVasive (NASDAQ:NUVA) Aren't Ideal

Dec 05
Capital Allocation Trends At NuVasive (NASDAQ:NUVA) Aren't Ideal

These 4 Measures Indicate That NuVasive (NASDAQ:NUVA) Is Using Debt Reasonably Well

Nov 13
These 4 Measures Indicate That NuVasive (NASDAQ:NUVA) Is Using Debt Reasonably Well

Calculating The Intrinsic Value Of NuVasive, Inc. (NASDAQ:NUVA)

Sep 22
Calculating The Intrinsic Value Of NuVasive, Inc. (NASDAQ:NUVA)

Capital Allocation Trends At NuVasive (NASDAQ:NUVA) Aren't Ideal

Sep 01
Capital Allocation Trends At NuVasive (NASDAQ:NUVA) Aren't Ideal

NuVasive Likely Undervalued, But It's Hard To Find Catalysts

Aug 17

Does NuVasive (NASDAQ:NUVA) Have A Healthy Balance Sheet?

Aug 11
Does NuVasive (NASDAQ:NUVA) Have A Healthy Balance Sheet?

NuVasive Non-GAAP EPS of $0.47 misses by $0.09, revenue of $310.5M beats by $4.12M

Aug 03

NuVasive: Industry Tailwinds More Than Fairly Priced

Jun 13

Calculating The Intrinsic Value Of NuVasive, Inc. (NASDAQ:NUVA)

Jun 01
Calculating The Intrinsic Value Of NuVasive, Inc. (NASDAQ:NUVA)

Investors Could Be Concerned With NuVasive's (NASDAQ:NUVA) Returns On Capital

May 11
Investors Could Be Concerned With NuVasive's (NASDAQ:NUVA) Returns On Capital

NuVasive (NASDAQ:NUVA) Has A Pretty Healthy Balance Sheet

Apr 20
NuVasive (NASDAQ:NUVA) Has A Pretty Healthy Balance Sheet

At US$56.32, Is NuVasive, Inc. (NASDAQ:NUVA) Worth Looking At Closely?

Mar 30
At US$56.32, Is NuVasive, Inc. (NASDAQ:NUVA) Worth Looking At Closely?

NuVasive's Turnaround Story Needs A Boost From Better Results

Mar 01

Investors Could Be Concerned With NuVasive's (NASDAQ:NUVA) Returns On Capital

Dec 28
Investors Could Be Concerned With NuVasive's (NASDAQ:NUVA) Returns On Capital

Should You Think About Buying NuVasive, Inc. (NASDAQ:NUVA) Now?

Dec 02
Should You Think About Buying NuVasive, Inc. (NASDAQ:NUVA) Now?

NuVasive (NASDAQ:NUVA) Has A Pretty Healthy Balance Sheet

Nov 11
NuVasive (NASDAQ:NUVA) Has A Pretty Healthy Balance Sheet

NuVasive, Inc. (NASDAQ:NUVA) Shares Could Be 32% Below Their Intrinsic Value Estimate

Oct 21
NuVasive, Inc. (NASDAQ:NUVA) Shares Could Be 32% Below Their Intrinsic Value Estimate

Be Wary Of NuVasive (NASDAQ:NUVA) And Its Returns On Capital

Sep 29
Be Wary Of NuVasive (NASDAQ:NUVA) And Its Returns On Capital

At US$59.79, Is It Time To Put NuVasive, Inc. (NASDAQ:NUVA) On Your Watch List?

Aug 18
At US$59.79, Is It Time To Put NuVasive, Inc. (NASDAQ:NUVA) On Your Watch List?

NuVasive Still Getting No Love With COVID-19 And Competitive Worries

Aug 12

Does NuVasive (NASDAQ:NUVA) Have A Healthy Balance Sheet?

Jul 27
Does NuVasive (NASDAQ:NUVA) Have A Healthy Balance Sheet?

Are Investors Undervaluing NuVasive, Inc. (NASDAQ:NUVA) By 21%?

Jun 17
Are Investors Undervaluing NuVasive, Inc. (NASDAQ:NUVA) By 21%?

Some Investors May Be Worried About NuVasive's (NASDAQ:NUVA) Returns On Capital

May 30
Some Investors May Be Worried About NuVasive's (NASDAQ:NUVA) Returns On Capital

Why We Think NuVasive, Inc.'s (NASDAQ:NUVA) CEO Compensation Is Not Excessive At All

May 12
Why We Think NuVasive, Inc.'s (NASDAQ:NUVA) CEO Compensation Is Not Excessive At All

Is NuVasive (NASDAQ:NUVA) Using Too Much Debt?

Mar 30
Is NuVasive (NASDAQ:NUVA) Using Too Much Debt?

Is Now The Time To Look At Buying NuVasive, Inc. (NASDAQ:NUVA)?

Mar 09
Is Now The Time To Look At Buying NuVasive, Inc. (NASDAQ:NUVA)?

Need To Know: NuVasive, Inc. (NASDAQ:NUVA) Insiders Have Been Buying Shares

Feb 16
Need To Know: NuVasive, Inc. (NASDAQ:NUVA) Insiders Have Been Buying Shares

A Look At The Fair Value Of NuVasive, Inc. (NASDAQ:NUVA)

Jan 26
A Look At The Fair Value Of NuVasive, Inc. (NASDAQ:NUVA)

NuVasive stock gains on study results of its X360 surgery approach

Jan 06

What Type Of Returns Would NuVasive's(NASDAQ:NUVA) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Jan 05
What Type Of Returns Would NuVasive's(NASDAQ:NUVA) Shareholders Have Earned If They Purchased Their SharesYear Ago?

財務状況分析

短期負債: NUVAの 短期資産 ( $728.3M ) が 短期負債 ( $582.6M ) を超えています。

長期負債: NUVAの短期資産 ( $728.3M ) が 長期負債 ( $614.4M ) を上回っています。


デット・ツー・エクイティの歴史と分析

負債レベル: NUVAの 純負債対資本比率 ( 80.1% ) は 高い と見なされます。

負債の削減: NUVAの負債対資本比率は、過去 5 年間で80.6%から89.1%に増加しました。

債務返済能力: NUVAの負債は 営業キャッシュフロー によって 十分にカバーされていません ( 17.5% )。

インタレストカバレッジ: NUVAの負債に対する 利息支払いEBIT ( 6.1 x coverage) によって 十分にカバーされています


貸借対照表


健全な企業の発掘